Ocular Therapeutix Free Cash Flow (Quarterly) Insights

Ocular Therapeutix Inc (OCUL)

4.32 -0.32 (-7.00%) USD | NASDAQ | Apr 25, 10:22

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-22.91M
September 30, 2023	-7.991M
June 30, 2023	-22.06M
March 31, 2023	-23.35M
December 31, 2022	-19.11M
September 30, 2022	-13.96M
June 30, 2022	-11.37M
March 31, 2022	-18.88M
December 31, 2021	-15.78M
September 30, 2021	-13.26M
June 30, 2021	-20.18M
March 31, 2021	-17.52M
December 31, 2020	-6.499M
September 30, 2020	-13.87M
June 30, 2020	-14.92M
March 31, 2020	-19.10M
December 31, 2019	-20.07M
September 30, 2019	-19.96M
June 30, 2019	-19.67M
March 31, 2019	-20.11M
December 31, 2018	-14.13M
September 30, 2018	-11.35M

Date	Value
June 30, 2018	-12.79M
March 31, 2018	-12.85M
December 31, 2017	-10.95M
September 30, 2017	-16.42M
June 30, 2017	-15.13M
March 31, 2017	-16.23M
December 31, 2016	-8.292M
September 30, 2016	-8.20M
June 30, 2016	-10.04M
March 31, 2016	-9.383M
December 31, 2015	-9.109M
September 30, 2015	-9.776M
June 30, 2015	-9.403M
March 31, 2015	-7.233M
December 31, 2014	-6.067M
September 30, 2014	-6.607M
June 30, 2014	-4.76M
March 31, 2014	-4.322M
December 31, 2013	-3.663M
September 30, 2013	-2.959M
June 30, 2013	-3.012M
March 31, 2013	-3.398M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-23.35M

Minimum

Mar 2023

-6.499M

Maximum

Dec 2020

-16.87M

Average

-18.88M

Median

Mar 2022

Free Cash Flow (Quarterly) Benchmarks